165 related articles for article (PubMed ID: 9420044)
1. Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.
Vandewoude K; Vogelaers D; Decruyenaere J; Jaqmin P; De Beule K; Van Peer A; Woestenborghs R; Groen K; Colardyn F
Antimicrob Agents Chemother; 1997 Dec; 41(12):2714-8. PubMed ID: 9420044
[TBL] [Abstract][Full Text] [Related]
2. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection.
Zhou H; Goldman M; Wu J; Woestenborghs R; Hassell AE; Lee P; Baruch A; Pesco-Koplowitz L; Borum J; Wheat LJ
J Clin Pharmacol; 1998 Jul; 38(7):593-602. PubMed ID: 9702843
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection.
Zhao Q; Zhou H; Pesco-Koplowitz L
J Clin Pharmacol; 2001 Dec; 41(12):1319-28. PubMed ID: 11762559
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
Boogaerts MA; Maertens J; Van Der Geest R; Bosly A; Michaux JM; Van Hoof A; Cleeren M; Wostenborghs R; De Beule K
Antimicrob Agents Chemother; 2001 Mar; 45(3):981-5. PubMed ID: 11181397
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules.
Glasmacher A; Hahn C; Molitor E; Marklein G; Sauerbruch T; Schmidt-Wolf IG
Mycoses; 1999; 42(11-12):591-600. PubMed ID: 10680434
[TBL] [Abstract][Full Text] [Related]
6. Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.
de Repentigny L; Ratelle J; Leclerc JM; Cornu G; Sokal EM; Jacqmin P; De Beule K
Antimicrob Agents Chemother; 1998 Feb; 42(2):404-8. PubMed ID: 9527794
[TBL] [Abstract][Full Text] [Related]
7. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.
Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
Pharmacotherapy; 1998; 18(2):295-301. PubMed ID: 9545149
[TBL] [Abstract][Full Text] [Related]
8. Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers.
Gubbins PO; McConnell SA; Gurley BJ; Fincher TK; Franks AM; Williams DK; Penzak SR; Saccente M
Pharmacotherapy; 2004 Apr; 24(4):460-7. PubMed ID: 15098799
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
[TBL] [Abstract][Full Text] [Related]
10. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.
Groll AH; Wood L; Roden M; Mickiene D; Chiou CC; Townley E; Dad L; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 2002 Aug; 46(8):2554-63. PubMed ID: 12121932
[TBL] [Abstract][Full Text] [Related]
11. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
Caillot D
Acta Haematol; 2003; 109(3):111-8. PubMed ID: 12714819
[TBL] [Abstract][Full Text] [Related]
12. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia.
Prentice AG; Warnock DW; Johnson SA; Taylor PC; Oliver DA
J Antimicrob Chemother; 1995 Oct; 36(4):657-63. PubMed ID: 8591940
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy and safety of itraconazole injection/oral solution sequential therapy for treatment of invasive fungal infection in intensive care unit].
; Qui HB
Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1012-6. PubMed ID: 19134307
[TBL] [Abstract][Full Text] [Related]
14. Characterization of itraconazole/2-hydroxypropyl-beta-cyclodextrin inclusion complex in aqueous propylene glycol solution.
Miyake K; Irie T; Arima H; Hirayama F; Uekama K; Hirano M; Okamaoto Y
Int J Pharm; 1999 Mar; 179(2):237-45. PubMed ID: 10053216
[TBL] [Abstract][Full Text] [Related]
15. Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.
Abdel-Rahman SM; Jacobs RF; Massarella J; Kauffman RE; Bradley JS; Kimko HC; Kearns GL; Shalayda K; Curtin C; Maldonado SD; Blumer JL
Antimicrob Agents Chemother; 2007 Aug; 51(8):2668-73. PubMed ID: 17517842
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis.
Reynes J; Bazin C; Ajana F; Datry A; Le Moing JP; Chwetzoff E; Levron JC
Antimicrob Agents Chemother; 1997 Nov; 41(11):2554-8. PubMed ID: 9371367
[TBL] [Abstract][Full Text] [Related]
17. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.
Böhme A; Just-Nübling G; Bergmann L; Shah PM; Stille W; Hoelzer D
J Antimicrob Chemother; 1996 Dec; 38(6):953-61. PubMed ID: 9023642
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
